Clopidogrel Actavis Dosage & Drug Information

Concise Prescribing Info

Contents

Clopidogrel bisulfate

Indications/Uses

Prevention of atherothrombotic events in MI (<35 days), ischaemic stroke (7 days-6 mth), established peripheral arterial disease; non-ST segment elevation acute coronary syndrome (unstable angina or non-Q wave MI) in combination w/ aspirin.

Dosage/Direction for Use

75 mg once daily. Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q wave MI) Loading dose: 300 mg as a single dose. Maintenance: 75 mg once daily w/ aspirin 75-325 mg daily.

Administration

May be taken with or without food.

Contraindications

Active pathological bleeding (eg, gastric ulcer or intracranial hemorrhage); severe hepatic failure. Childn. Pregnancy & lactation.

Special Precautions

Patient w/ high risk of increased bleeding in trauma, surgery or other pathological states. Discontinue 5 days pre-op. Renal impairment.

Adverse Reactions

Bleeding, heartburn, warmth, abdominal pains, diarrhea.

View ADR Reporting Link

Drug Interactions

Warfarin, glycoprotein IIb/IIIa inhibitors, aspirin, NSAIDs.

MIMS Class

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

ATC Classification

B01AC04 - clopidogrel ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.

Regulatory Classification

P₁S₁S₃

Presentation/Packing

Form

Clopidogrel Actavis film-coated tab 75 mg

Packing/Price

30's

Clopidogrel Actavis

clopidogrel

Manufacturer:

Teva

Distributor:

Agencia Lei Va Hong

KLN Pharma